Story Stocks®
- Q1 revenue grew modestly by approximately 2% in constant currency to $2.5 bln, with strength concentrated in banking (+13%) and retail/travel/e-commerce (+6%), driven by large transformational deals and continued share gains across clients.
- Media & communications posted +3% growth, supported by global entertainment demand, while technology & consumer electronics (-6%) and healthcare (-6%) were key drags due to weaker volumes, automation impacts, and changes in end-market dynamics such as Medicare membership shifts.
- Margin pressure stemmed from several factors, including upfront investments in AI-driven solutions (which carry near-term dilution before scaling), excess capacity tied to anticipated volumes, and ongoing mix shift toward offshore delivery and higher-value contracts that initially compress profitability.
- Additionally, lower-than-expected client volumes, particularly in healthcare and tech, combined with continued offshore migration (2 pts headwind), weighed on both revenue and margin realization in the quarter.
- Q2 guidance disappointed, with EPS expected at $2.57-$2.69 and revenue of $2.46-$2.49 bln, implying only 1-2% constant currency growth and continued margin pressure (11.8%-12.1%), as geopolitical uncertainty, uneven client demand, and lingering volume softness persist into the near term.
Briefing.com Analyst Insight:
CNXC’s weak Q1 profitability and soft Q2 outlook highlight the growing pains associated with its transition toward AI-enabled, higher-value services. While strategic initiatives, such as expanding its iX Suite and increasing exposure to complex, technology-driven contracts, are gaining traction, they are creating near-term headwinds through upfront investment costs and delayed margin realization. Encouragingly, demand trends remain solid in key verticals like banking and travel, and management pointed to strong AI bookings and pipeline momentum. However, persistent volume softness in healthcare and tech, offshore mix shifts, and macro/geopolitical caution are weighing on near-term visibility. The reaffirmed FY26 guidance suggests confidence in a second-half recovery driven by cost actions, scaling AI programs, and improved capacity utilization, but investors appear skeptical given the lack of near-term earnings leverage.